Improvement in Liver Stiffness in Pediatric Patients with Hepatitis C Virus after Treatment with Direct Acting Antivirals
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 233, 126-131
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio indexLiver International, 2016
- Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?World Journal of Gastroenterology, 2016
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological responseJournal of Hepatology, 2013
- Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or CGastroenterology, 2012
- The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®Clinics and Research in Hepatology and Gastroenterology, 2012
- Transient elastography (FibroScan)Gastroentérologie Clinique Et Biologique, 2008
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective studyGut, 2006
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003